For an individual to build a successful career, a lot of sacrifices need to be made. The individual needs to be ready to do what is required and be willing to sacrifice some things for the greater good of your career. You have an obligation to have determination, confidence in what you want and be ambitious. The business industry is filled with people who strive to make their dreams come true and are ready to do what is required even if it means sacrificing his/her friends. Jeanmarie Guenot is one woman who has been able to establish a successful career in the biotech and pharmaceutical industry by understanding what she wants and going for it.
JeanMarie Guenot has been able to bring about change in the industry as she believes she is the woman for the job on takeda.com. Her achievements and accomplishments have been numerous considering she has been in the industry for nearly twenty years. Her significant achievements include building companies, developing and discovering new drugs and negotiating acquisitions & mergers for various companies. While at the University of California where she earned her Ph.D., JeanMarie Guenot was trained in both medical and physical chemistry. After clearing her training, Guenot decided to join the business industry as it was time to apply what she had been taught in her training sessions.
From her LinkedIn account, we can see that she began her career at Atlas Venture. While working at Atlas, she was responsible for managing the capital investments while establishing life science organizations. She has an idea of how important it was for her to gain the experience she was gaining as it would help in the near future. With this in mind, JeanMarie gave her best in everything she did. She began her scientific career at Hoffmann-La Roche where she was employed as a business advisor. She later joined PDL BioPharma where she was the Vice President and offered her services to the firm.
JeanMarie Guenot is currently heading Amphivena Therapeutics Inc. as its President and CEO. The company majorly focuses on developing antibody therapeutics that are aimed at helping patients who have blood cancer. As the company’s President and CEO, she is responsible for overseeing the research operations and helps in the development of therapies to help in curing blood cancers. She believes as time goes by, she will assist the firm to succeed in what it does as she is determined and confident with what she does.
Find more about Jeanmarie Guenot: http://amphivena.com/amphivena_leaders/jeanmarie-guenot-ph-d/